In MLL1-r AML cells, they show a decline in ATAC-Seq and RNA-Seq peak densities in MLL1/MLL-FP-target genes, including HOXA9, MEIS1, MYB and MYC, and their targets. The gene discussed is KMT2A; the disease is acute myeloid leukemia.